Trilateral Project 24.1-Biotechnology 157

In principle, the same applies as under item 2.2.1, because there is no difference for the judgement on novelty whether the claimed invention is directed to a DNA sequence or a protein sequence. However, novelty might exceptionally be acknowledged for polypeptide fragments carrying the defined epitope not disclosed in the prior art document.